LMU-founded antibody reagent supplier ChromoTek has been picked up after raising funding from Bayern Kapital and HTGF in 2010.

Evonik and Mectalent have exited the bone implant developer in an acquisition by Globus Medical that follows nearly $12m in funding.

ABN Amro Ventures and commercial partner London Stock Exchange Group helped the digital investment platform developer close its latest round.

Media group Schibsted has exited the aftersales experience platform, which has been purchased by financial technology developer Klarna.

The University of Oslo sensor software spinout has started trading on the Merkur Market, part of the Oslo Stock Exchange.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Incubated by Vision Institute, the retinal disease gene therapy developer has secured $52.8m in a round co-led by UPMC Enterprises.

QUB spinout ProAxsis has been fully acquired by NetScientific, which previously backed the company’s sole funding round in 2014.

The telecommunications company's newly formed Telefónica Tech Ventures will carry over nine portfolio companies and invest in 15 over the next three years.

The retinal disease gene therapy developer has secured $52.8m in a round co-led by UPMC Enterprises that will go toward further developing its drug pipeline.